Rapid Novor offers Antibody sequencing, mass spectrometry and characterization. Services should be matched to the intended study and assay requirements.
Company database
Profiles, sources, and comparisons are open. Choose a field on the left to see its companies.
Search & refine Filters update automatically
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
473 matching companiesShowing 385–408 / 473
An Agilent-owned Canadian CDMO with officially disclosed pDNA, mRNA, and LNP formulation capabilities.
Biodextris offers Vaccine and biologics analytical development, validation and quality testing. This is the analytical service business of an integrated CRO/CDMO.
军科正源 (UP Pharma) offers Protein characterization, PK, ADA, neutralizing antibodies and biomarkers. Services should be matched to the intended study and assay requirements.
百趣生物 (Biotree) offers Protein characterization, developability and multiomics biomarkers. Services should be matched to the intended study and assay requirements.
耀海生物 (Yaohai Bio-Pharma) offers Recombinant proteins, nanobodies and nucleic-acid characterization and QC. This is the analytical service business of an integrated CRO/CDMO.
东曜药业 (BioDlink) offers Antibody and ADC characterization, higher-order structure and comparability. This is the analytical service business of an integrated CRO/CDMO.
迈百瑞 (MabPlex) offers Antibody and ADC structure, potency, impurities and CMC analytics. This is the analytical service business of an integrated CRO/CDMO.
鼎康生物 (Chime Biologics) offers Biologics analytical development, characterization, release and stability. This is the analytical service business of an integrated CRO/CDMO.
ProBio offers Antibody and gene-therapy characterization, bioassays and quality control. This is the analytical service business of an integrated CRO/CDMO.
Offers mRNA drug substance and drug product services, including process development, analysis, and product characterization. Each site's project scope requires confirmation.
LOTTE Biologics offers Biologics method transfer, potency, release and stability testing. This is the analytical service business of an integrated CRO/CDMO.
BINEX offers Biologics analytical development, validation and protein characterization. This is the analytical service business of an integrated CRO/CDMO.
Prestige Biologics offers Biologics analytical testing and analytical development within CDMO services. This is the analytical service business of an integrated CRO/CDMO.
Offers mRNA process development and cGMP manufacturing based on microbial, DNA, and RNA production and analytical capabilities. Capabilities are not necessarily equivalent across all AGC sites.
KBI Biopharma offers Biologics structure, biophysical characterization, potency and analytics. This is the analytical service business of an integrated CRO/CDMO.
Abzena offers Antibody and bioconjugate characterization and analytical development. This is the analytical service business of an integrated CRO/CDMO.
Offers liquid, lyophilized, and complex injectable formulation development, compatibility and stability studies, and clinical-to-commercial sterile manufacturing for small molecules and biologics.
FUJIFILM Biotechnologies offers Biologics biochemical and biophysical characterization, potency and GMP testing. This is the analytical service business of an integrated CRO/CDMO.
Northway Biotech offers Biologics analytical development, characterization and quality control. This is the analytical service business of an integrated CRO/CDMO.
Aragen Life Sciences offers Protein characterization, analytical development and clinical bioanalysis. This is the analytical service business of an integrated CRO/CDMO.
The integrated PROTAC offering brochure lists medicinal chemistry, bioassays, solubility / permeability / stability, PK/PD, in vivo pharmacology, safety, and toxicology, supporting lead optimization through candidate selection.
VelaLabs offers Biologics characterization, GMP QC, potency and clinical bioanalysis. Services should be matched to the intended study and assay requirements.
A dedicated page describes linker / ligand synthesis, biophysical and cellular degradation evaluation, PK/PD, toxicology, IND support, and DAC services.
Coverage expands from sourced records; this database does not claim all biopharma companies.